Management of patients with adrenal cancer: recommendations of an international consensus conference
…, GD Hammer, M Korobkin, FP Worden - Endocrine-related …, 2005 - erc.bioscientifica.com
Adrenocortical carcinomas are rare, highly malignant tumors that account for only 0.2% of
deaths due to cancer. Given the limited number of patients seen in most medical centers with …
deaths due to cancer. Given the limited number of patients seen in most medical centers with …
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
Background The optimal cumulative dose and timing of cisplatin administration in various
concurrent chemoradiotherapy protocols for nonmetastatic head and neck squamous cell …
concurrent chemoradiotherapy protocols for nonmetastatic head and neck squamous cell …
[HTML][HTML] Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study
…, MS Kies, AA Forastiere, FP Worden… - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Patients with advanced, incurable thyroid cancer not amenable to surgery or
radioactive iodine (131 I) therapy have few satisfactory therapeutic options. This multi-institutional …
radioactive iodine (131 I) therapy have few satisfactory therapeutic options. This multi-institutional …
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
… HPV type and copy number were reported in Worden et al. p53 exons 4 to 9 were amplified
by using the primers given in Appendix Table A1. Products from two polymerase chain …
by using the primers given in Appendix Table A1. Products from two polymerase chain …
Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose–effect relationships for the swallowing structures
…, TH Lyden, MJ Haxer, M Feng, FP Worden… - International Journal of …, 2007 - Elsevier
Purpose: To present initial results of a clinical trial of intensity-modulated radiotherapy (IMRT)
aiming to spare the swallowing structures whose dysfunction after chemoradiation is a …
aiming to spare the swallowing structures whose dysfunction after chemoradiation is a …
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
AG Sacco, FP Worden - OncoTargets and therapy, 2016 - Taylor & Francis
The majority of patients with head and neck squamous cell carcinoma (HNSCC) present with
locally advanced disease, which requires site-specific combinations of surgery, radiation, …
locally advanced disease, which requires site-specific combinations of surgery, radiation, …
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number
Purpose To test induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CRT)
or surgery/radiotherapy (RT) for advanced oropharyngeal cancer and to assess the effect …
or surgery/radiotherapy (RT) for advanced oropharyngeal cancer and to assess the effect …
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 …
…, D Yin, K Pritchard-Jones, I Judson, FP Worden… - The lancet …, 2010 - thelancet.com
Background Figitumumab is a fully human IgG2 monoclonal antibody targeting the insulin-like
growth-factor-1 receptor (IGF-1R). Preclinical data suggest a dependence on insulin-like …
growth-factor-1 receptor (IGF-1R). Preclinical data suggest a dependence on insulin-like …
[HTML][HTML] Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results
…, HM Kim, TH Lyden, MJ Haxer, FP Worden… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose To assess clinical and functional results of chemoradiotherapy for oropharyngeal
cancer (OPC), utilizing intensity-modulated radiotherapy (IMRT) to spare the important …
cancer (OPC), utilizing intensity-modulated radiotherapy (IMRT) to spare the important …
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing
…, TN Teknos, DB Chepeha, FP Worden… - International Journal of …, 2004 - Elsevier
PURPOSE: Locoregional (LR) failures near the base of the skull, and their relationships to
the targets in the high neck, were examined in a series of patients who underwent intensity-…
the targets in the high neck, were examined in a series of patients who underwent intensity-…
